Roche Group entered into a strategic license collaboration with a leading cell therapy-focused venture targeting cancer, as Roche’s Genentech inked a deal with Adaptimmune Therapeutics.…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.